Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Targher and Christopher Byrne.
Giovanni Targher
Connection Strength
9.514
Christopher Byrne
  1. Does high LDL-cholesterol cause cardiovascular disease? Expert Rev Clin Pharmacol. 2019 02; 12(2):91.
    View in: PubMed
    Score: 0.801
  2. Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease? Hepatology. 2018 11; 68(5):1668-1671.
    View in: PubMed
    Score: 0.790
  3. Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease. Eur Heart J. 2018 09 21; 39(36):3398.
    View in: PubMed
    Score: 0.787
  4. Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults. BMJ. 2018 Jul 12; 362:k2734.
    View in: PubMed
    Score: 0.776
  5. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018 02; 14(2):99-114.
    View in: PubMed
    Score: 0.748
  6. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol. 2017 05; 13(5):297-310.
    View in: PubMed
    Score: 0.705
  7. Obesity: Metabolically healthy obesity and NAFLD. Nat Rev Gastroenterol Hepatol. 2016 08; 13(8):442-4.
    View in: PubMed
    Score: 0.674
  8. Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram. Hepatology. 2016 08; 64(2):684-5.
    View in: PubMed
    Score: 0.658
  9. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19. Diabetes Metab. 2020 11; 46(6):505-507.
    View in: PubMed
    Score: 0.221
  10. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2020 07 24; 30(8):1236-1248.
    View in: PubMed
    Score: 0.221
  11. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. Gut. 2020 08; 69(8):1545-1547.
    View in: PubMed
    Score: 0.221
  12. Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes Metab. 2020 09; 46(4):335-337.
    View in: PubMed
    Score: 0.220
  13. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography. Diabetes Metab. 2020 04; 46(2):150-157.
    View in: PubMed
    Score: 0.209
  14. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease. J Hepatol. 2019 10; 71(4):802-810.
    View in: PubMed
    Score: 0.208
  15. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. Hepatology. 2019 07; 70(1):142-153.
    View in: PubMed
    Score: 0.206
  16. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis. Liver Int. 2019 04; 39(4):758-769.
    View in: PubMed
    Score: 0.202
  17. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy. Arterioscler Thromb Vasc Biol. 2018 12; 38(12):2854-2861.
    View in: PubMed
    Score: 0.199
  18. Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes. Diabetes Metab. 2018 12; 44(6):473-481.
    View in: PubMed
    Score: 0.196
  19. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. Metabolism. 2018 10; 87:1-12.
    View in: PubMed
    Score: 0.193
  20. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy. Metabolism. 2018 08; 85:305-312.
    View in: PubMed
    Score: 0.192
  21. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2018 02; 41(2):372-382.
    View in: PubMed
    Score: 0.188
  22. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis. Metabolism. 2018 02; 79:64-76.
    View in: PubMed
    Score: 0.185
  23. Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure. PLoS One. 2017; 12(3):e0173398.
    View in: PubMed
    Score: 0.177
  24. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014 Feb 21; 20(7):1724-45.
    View in: PubMed
    Score: 0.143
  25. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front Endocrinol (Lausanne). 2021; 12:604100.
    View in: PubMed
    Score: 0.058
  26. ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis. Am J Gastroenterol. 2020 09; 115(9):1544.
    View in: PubMed
    Score: 0.056
  27. Abnormal liver enzymes in children and infants with COVID-19: A narrative review of case-series studies. Pediatr Obes. 2020 12; 15(12):e12723.
    View in: PubMed
    Score: 0.056
  28. Extrapulmonary complications of COVID-19: A multisystem disease? J Med Virol. 2021 01; 93(1):323-335.
    View in: PubMed
    Score: 0.056
  29. Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study. Nephron. 2020; 144(7):347-350.
    View in: PubMed
    Score: 0.055
  30. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020 Jul; 43(7):e72-e74.
    View in: PubMed
    Score: 0.055
  31. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol. 2020 Mar 28; 8(1):18-24.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.